Zydus gets US regulator’s PAS for generic version of Mycophenolate Mofetil for injection


PTI, Mar 21, 2022, 10:46 AM IST

New Delhi: Zydus Lifesciences Ltd on Monday said it has received prior approval supplement nod from the US health regulator to market its generic version of Mycophenolate Mofetil for injection used in combination with other drugs for prophylaxis of organ rejection in patients receiving renal, hepatic or cardiac transplants.

The Prior Approval Supplement (PAS) granted by the US Food & Drug Administration (USFDA) is for Mycophenolate Mofetil for injection of strength 500 mg/vial, the generic equivalent of CellCept injection, the company said in a regulatory filing.

As per the USFDA, PAS refers to a change in either manufacturing or testing of a product applicable to either a specific batch of product or all products that requires the regulator’s approval prior to implementation of such changes or sale of the product.

The company said the PAS it has received is for site transfer into Jarod. ”The injection will be manufactured at the group’s injectables manufacturing facility at Jarod near Vadodara in Gujarat. This site was recently inspected by the USFDA,” it added.

In September 2017, the group was granted approval to market Mycophenolate Mofetil for injection in the strength of 500 mg/vial. Mycophenolate Mofetil is indicated for use in combination with other drugs such as cyclosporine and corticosteroids for the prophylaxis of organ rejection in patients receiving renal, hepatic or cardiac transplants, the company said. The group now has 330 approvals and has so far filed over 400 abbreviated new drug applications since the commencement of the filing process in FY 2003-04, it added.

Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.

Top News

Alphabet gets CCI’s clearance to acquire stake in Flipkart

‘COVID was different’: SC bemoans distribution of free ration

Nagarjuna’s younger son Akhil Akkineni engaged

People getting heartburns after I became CM for second time: Siddaramaiah

Newborn baby kidnapped from Kalaburagi hospital in Karnataka

Gukesh draws with Liren in second game of World Chess Championship

All about ‘One Nation One Subscription’ scheme

Related Articles More

Genetic vulnerability for low insulin, unhealthy fat major causes for diabetes in South Asians: Study

Study links overthinking to ‘constant communication’ between brain’s fear-centre, social behaviour

Mangaluru: Campco opposes WHO’s claim of arecanut being carcinogenic

10 month baby gets new heart, new life

World COPD Day: Know your lung function

MUST WATCH

Grafting

Coconut Flower

Prakash Belawadi

Naxal Leader Vikram Gowda

Christmas Cake Fruit Mixing


Latest Additions

Alphabet gets CCI’s clearance to acquire stake in Flipkart

‘COVID was different’: SC bemoans distribution of free ration

Telugu actor Shri Tej booked for alleged cheating, false marriage promise

Five arrested in connection with botched angioplasty deaths at Gujarat hospital

Deceased Kannur official’s widow moves Kerala HC for CBI probe into his death

Thanks for visiting Udayavani

You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.